Product Information
LAMICTAL ODT 25 MG TABLET is a brand product labeled by GlaxoSmithKline LLC, priced at $12.8173 per EA under NDC 00173077202. Its NADAC has been published 252 times since Nov 28, 2013.
FDA first approved this application on May 8, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the lamotrigine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
25 mg/1
Manufacturer
GlaxoSmithKline LLCNDC
00173077202
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LAMOTRIGINEApproval Type
New Drug (NDA)
FDA Application
NDA022251FDA Approved
5/8/2009
TE Code
AB
On Market Since
6/5/2009
Pharmacological Classes
Price Statistics
The NADAC for LAMICTAL ODT 25 MG TABLET has been published 252 times since Nov 28, 2013, and over the history we have for it it has risen 120.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.8173 per EA |
|---|---|
| All-time high | $12.8328 (Nov 12, 2025) |
| All-time low | $5.8019 (Nov 28, 2013) |
| 52-week high | $12.8328 |
| 52-week low | $12.7739 |
| Median price | $8.9256 |
| Average price | $10.0106 |
| Largest weekly change | +42.9% (Jun 19, 2024) |
| Weeks tracked | 252 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LAMICTAL ODT 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMICTAL ODT 25 MG TABLET, manufactured by GlaxoSmithKline LLC, is $12.8173 per EA (NDC 00173077202), effective Aug 19, 2026.
How has the price of LAMICTAL ODT 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMICTAL ODT 25 MG TABLET has risen 120.9%. It has been tracked across 252 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LAMICTAL ODT 25 MG TABLET?
Since Nov 28, 2013, the NADAC for LAMICTAL ODT 25 MG TABLET has ranged from a low of $5.8019 (Nov 28, 2013) to a high of $12.8328 (Nov 12, 2025), with a median of $8.9256 per EA.
Are there cheaper alternatives to LAMICTAL ODT 25 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LAMOTRIGINE 25 MG DISPER TAB, is $0.1497 per EA — about 99% below LAMICTAL ODT 25 MG TABLET.
Who manufactures LAMICTAL ODT 25 MG TABLET?
LAMICTAL ODT 25 MG TABLET (NDC 00173077202) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.